Marchex, Inc.
corporate_fare Company Profile
Marchex, Inc. (NASDAQ:MCHX) is a publicly traded company in the Technology sector. Wiseek has independently scored 19 items for MCHX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for MCHX spans 10-Q, 8-K, SCHEDULE 13D, DEFM14A.
Recent high-impact activity:
- Marchex Q2 2026: Revenue Down 6%, Archenia Deal Terms Revealed
- Marchex Q2 Revenue Falls 6%, Swings to Net Loss; Guides Q3 Pro Forma Revenue $16M-$16.5M
- Marchex Q2 Revenue Dips 6% but Pro Forma Archenia Combo Shows $15.5M and Positive EBITDA
- Marchex Closes Archenia Deal, Projects $60M Revenue and 10%+ EBITDA Margins
- Chairman Russell Horowitz Increases Stake to 18.5% via $4.9M Convertible Notes from Archenia Acquisition
Financial Snapshot
Short Interest & Short Volume
1.83 days to coverFINRA reported short interest of 66,288 shares in MCHX as of the September 15, 2026 settlement, a 132.0% increase from the prior period — about 1.8 days to cover at its recent average daily volume. On October 2, 2026, 38.2% of MCHX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.